KM Biologics Co., Ltd.
Records under this name other than the patents KM Biologics Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.
Back to KM Biologics Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,748,132 | Process for Preparing Inclusion Body-Forming Protein Formerly held In force · High confidence | In force | High confidence | |
| US 9,345,756 | LPS Vaccine Formerly held In force · High confidence | In force | High confidence | |
| US 10,279,025 | LPS Vaccine Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,701,724 | Vaccine for Preventing Porcine Edema Disease Formerly held In force · High confidence | In force | High confidence | |
| US 10,253,072 | Prophylactic Vaccine Against Egg Drop Syndrome (EDS) Formerly held In force · High confidence | In force | High confidence | |
| US 10,774,321 | Method for Monomerizing Matrix Metalloproteinase 7 (MMP-7) Aggregate Formerly held In force · High confidence | In force | High confidence | |
| US 10,160,979 | Pharmaceutical Composition for Treatment And/Or Prevention of Hepatitis C Formerly held In force · High confidence | In force | High confidence | |
| US 11,033,661 | Anti-Adhesion Material and Substitute Biomembrane Using Decellularized Tissue Formerly held In force · High confidence | In force | High confidence | |
| US 8,883,165 | Modified Peptide Vaccine Derived from Influenza M2 Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 8,759,018 | Method for Determining Treatment of Disseminated Intravascular Coagulation Lapsed on the fee record Ended Jun 24, 2026 · High confidence | Lapsed on the fee record | Ended Jun 24, 2026 | High confidence |